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Introduction
Biofilms are the major form of bacterial organisation and are a common problem in chronic infections (1, 2) . For the bacterium Pseudomonas aeruginosa, chronic infection and biofilm formation is the main cause of mortality for sufferers of cystic fibrosis (3) . Biofilms display an increased persistence and tolerance to antibiotics (4) . Physiologically, biofilm formation is associated with high levels of the secondary messenger c-di-GMP (5, 6) , which is synthesised by diguanylate cyclases (DGC) from two GTP molecules (7) . Reduction in c-di-GMP levels (8) can be achieved by NO stimulation, leading to biofilm dispersal, thereby allowing for the treatment of infectious diseases (9) .
Biofilm dispersion is linked to c-di-GMP hydrolysis by two types of phosphodiesterases (PDE) (10) with either an EAL (11) or a HD-GYP (12) motif. The two classes differ with respect to their hydrolysis products. HD-GYP domains hydrolyse c-di-GMP into two GMP molecules and have been shown to utilise trinuclear iron binding (13) . EAL domains, however, hydrolyse c-di-GMP to the linear di-nucleotide 5'-pGpG and additionally require a dimerisation event for PDE activation (14) .
EAL domains have been identified to contain two key surface helices providing a binding groove for an antiparallel dimer formation (15, 16) . In addition to the EAL motif, a second conserved DDFGTG(YSS) sequence motif coordinates the Mg 2+ ions required for activity (14) . Domains with a degenerate DDFGTG and EAL motif are catalytically inactive and instead function as c-di-GMP sensor proteins (17) .
EAL phosphodiesterase domains often occur in tandem with a diguanylate cyclase domain, in a single protein (18) . A structure of these dual domain proteins is known from the DGC-PDE c-di-GMP sensor protein LapD (19) . Conversion to the sensor is explained by a lack of the conserved EAL and DDFGTG motifs required for PDE activity. The determination of the structure of LapD provides insight into the regulation of nucleotide binding, as the isolated EAL domain can bind c-di-GMP, but in the tandem domain structure the nucleotide-binding pocket is obstructed. For proteins with dual activity, the underlying question is how the two opposing activities of cyclase and phosphodiesterase are controlled.
We have studied the tandem domain protein MorA (Motility Regulator A), conserved across
Pseudomonas species (20) . Additional to PDE and DGC domains, the cytosolic segment contains four PAS sensory domains (Per-Arnt-Sim homology) (21) . The protein is localised to the membrane by two N-terminal transmembrane helices and can affect bacterial motility (20) . MorA has been linked to fimbriae and flagella formation, prerequisites for biofilm formation and dispersal respectively (22, 23) . The protein is also reported to control the timing of flagella development and regulate sensory chemotaxis pathways (20) . The C-terminal PDE domain of MorA shows intact DDFGTG and EAL motifs, indicative of phosphodiesterase activity.
Here, we report the catalytic activity and structure of the tandem DGC-PDE fragment from MorA in the absence and presence of c-di-GMP and two structures of the isolated PDE in absence of nucleotide, but distinguished by dimerisation. Our data describe two states of the PDE nucleotidebinding pocket. The four structures suggest that dimerisation is involved in the formation of the nucleotide-binding pocket and catalytic activity. Understanding of PDE activation is highly sought after as biofilm dispersal results in bacteria becoming susceptible to antibiotics.
Materials and methods

Molecular biology and protein purification
Genomic DNA of P. aeruginosa PAO1 was isolated using the DNeasy blood and tissue kit (Qiagen).
MorA gene PA4601 was amplified by PCR using Phusion Polymerase (Finnzymes); PCR fragments were restriction digested and inserted into the expression vector pET-28a (Novagen For recombinant expression of all proteins, BL21 DE3 E. coli competent cultures were grown in LB medium and induced by 1 mM isopropyl-beta-D-thiogalactopyranoside (Melford) at an optical density OD 600 of 0.6. The cultures were collected after 20 h growth at 18 °C by centrifugation. Cells from 2 litre cultures were resuspended in 50 ml 50 mM HEPES buffered at pH 7.5 with 300 mM NaCl, 5%
glycerol, lysed by sonication, and centrifuged at 16,000 rpm for 40 min (Avanti centrifuge, Beckman JA25.50 rotor). The supernatant was loaded onto 4 ml Ni-NTA resin (Qiagen), equilibrated with buffer A (50 mM HEPES buffered at pH 7.5 with 300 mM NaCl, 2 mM MgCl 2 , 5% glycerol, 2 mM β-mercaptoethanol and 20 mM imidazole), followed by washes with buffer A containing 80 mM imidazole and elution using buffer A containing 300 mM imidazole. Following concentration over spin concentrators (Generon), the eluate was loaded onto an S75 16/600 size exclusion column (GE) equilibrated in 50 mM HEPES buffered at pH 7.5 with 300 mM NaCl, 2 mM MgCl 2 and 2 mM β-mercaptoethanol. Fractions containing the desired protein, confirmed by SDS-PAGE, were pooled and concentrated using spin concentrators (Generon).
Enzymatic assay.
Activity of MorA fragments was determined by an enzyme assay followed by HPLC analysis of nucleotides, adapted from (24) . Enzymes were used at a concentration of 40 µM; these were mixed with 0.1 mM GTP (Biolog) in 50 mM HEPES buffered at pH 7.5, with 300 mM NaCl, 2 mM MgCl 2 and 2 mM β-mercaptoethanol to 200 µl and incubated at room temperature for 1 hour. Samples were then run on a combination of a C4 and a C18 RPC column (Vydac), using a Shimadzu HPLC system, in buffer A (100 mM KPO 4 buffered at pH 6) with an elution gradient of 15 min into buffer B (70% buffer A with 30% methanol). Absorbance at 254 nm was used for detection. The system was calibrated using GTP (Sigma), 5'-pGpG (Biolog) and c-di-GMP, prepared by enzymatic synthesis from GTP, using purified YdeH as described in (25).
Bis-4pNPP analysis
PDE activity was measured in 1 ml total volume containing 0.4 mg/ml protein, 5 mM bis-4pNPP
(Sigma) and 50 mM Tris pH 9.2 with 5 mM MgCl 2 and 50 mM NaCl. The reaction was carried out at 37 °C. After 180 min the absorbance of the hydrolysed product was measured at 405 nm using a nanodrop spectrophotometer (Thermo Scientific). Controls contained heat inactivated proteins (100 °C, 5 min).
Structure determination and analysis
Purified proteins were crystallised in sitting drop 96-well plates using a Gryphon nanodrop dispenser (Art Robbins Instruments). Crystal hit optimisation was carried out using a Minstrel DT alchemist (Rigaku). Data were collected at the Southampton Diffraction Centre, the Diamond Light Source (DLS, Oxford) and the European Synchrotron Radiation Facility (ESRF, Grenoble). Data reduction, molecular replacement and refinement were carried out with CCP4 (26) and Phenix (27, 28) ; models were built using Coot (29) and automated water structure building in ArpWarp (30) ( Table 1) .
Dyndom was used to determine hinge regions (31) . PISA was used to calculate protein-protein interfaces (32) . Pymol was used to create figures (Schrödinger). 
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Results ands Discussion
Activity assay
To confirm that MorA is a suitable system to study bi-functional c-di-GMP regulation, we first ensured that MorA has diguanylate cyclase and phosphodiesterase activities. Our analysis is based on RPC-HPLC separation of nucleotide products. When an isolated DGC 978-1144 fragment was incubated with GTP, a retention product at 10 minutes is observed that corresponds to the c-di-GMP standard (Fig. 1A) . This indicates MorA has diguanylate cyclase activity.
To study the bi-functional enzyme, we incubated the MorA fragment containing both DGC and PDE domains (DGC-PDE 978-1409 ) with GTP. HPLC analysis of reaction products showed a peak with a decreased retention time, compared with c-di-GMP that corresponds to the 5'-pGpG standard (Fig.   1A ). Since no c-di-GMP was added in this experiment this indicates MorA's DGC produced c-di-GMP, which we observed as a small peak, consistent with the standard. However, the majority is converted to the linear nucleotide indicating MorA also has phosphodiesterase activity. The PDE containing fragments were further tested with the generic PDE substrate bis (p-nitrophenyl) phosphate (Table S1 ), confirming activity in the PDE domain.
To corroborate the DGC activity in the tandem DGC-PDE fragment, we mutated the PDE domain to obtain a catalytically inactive variant. To do this, the DDFGTG sequence motif was replaced with NNFGTG (D1310N and D1311N) . The two aspartates that were replaced coordinate the Mg 2+ ions required for activity (14) . HPLC analysis of reaction products after incubation with GTP showed a peak that corresponds to the c-di-GMP standard (Fig. 1A) . Thus, the mutant DGC-PDE fragment retained DGC activity but was unable to produce 5'-pGpG, indicating the mutation renders the PDE inactive (Table S1 ). (Fig. 1B) (35) . The DGC is nucleotide free and the nucleotide recognising helix α2 is disordered. The conformation seen does not preclude DGC dimerisation. MorA's PDE forms the canonical (β/α) 8 barrel in which the first beta strand is reversed (11), with respect to classic TIM topology ( Fig. 1C) (36) . The open conformation is stabilised by direct contact between residues K1076 and E1213 located on the DGC-α4 and PDE-α4' helices (SFig. 1). In the open conformation, both the PDE and DGC active sites are accessible.
An interesting feature of the MorA DGC-PDE 978-1409 mutant is the local structure around helix PDE-α5. The PDE-α5 helix in MorA is extended and consists of residues G1315 to Q1324, resulting in the removal of the DDFGTG motif from the active site, which would be required for Mg 2+ coordination and activity. A nucleotide free structure of the wild type PDE was determined using the isolated fragment, PDE . Intriguingly, this monomeric PDE 1145-1409 structure shows the same features as the MorA DGC-PDE 978-1409 mutant with an extended PDE-α5 helix in a Mg 2+ free state and the DDFGTG motif removed from the active site ( Fig. 2A) . Since formation of the helix PDE-α5 extension removes catalytic residues from the active site, we have named this helix repressor helix (R helix). It is known that dimerisation regulates PDE activity and hence we went on to characterise a structure of a PDE dimer to investigate the nature of this structural rearrangement.
PDE dimerisation influences the conformation of the R helix
To promote dimer formation, we crystallised the isolated PDE 1145-1409 domain of MorA in the presence of 5'-pGpG. Crystallisation yielded a nucleotide-free dimer with contacts around the α5-helix (R helix) and the α6 helix (Fig. 2B) . PDE domain dimers have been previously identified (Table S2) (15-17, 19, 37, 38) . PDE dimerisation involving PDE-α6 and the R helix has implications for active site formation. The PDE dimer contact between residues Y1316 and S1317 stabilises the loop formed by residues G1315 to S1318 and thus stabilises a state in which the R helix is shortened (L1319 to Q1324) ( Fig. 2A) . The shorter conformation of the R helix is consistent with the previously solved catalytically active c-di-GMP bound structure from T. denitrificans phosphodiesterase (PDB 3N3T).
An extended R helix (G1315 to Q1324), as seen in the nucleotide-free structures, is not compatible with dimer formation, as it would lead to clashes around the dimer interface and not allow residues Y1316 and S1317 of the 1310 DDFGTGYSS 1318 motif to contribute to dimer formation. Conservation of the YS residues is, therefore, explained by their involvement in PDE dimerisation (Fig. 2) .
Dimerisation around the R helix, therefore, stabilises the DDFGTGYSS motif into an extended loop conformation. However, no nucleotide or Mg 2+ are present in the active site. The dimeric PDE structure is presumably observed post-hydrolysis, where the product 5'-pGpG has left the binding site.
To understand the significance of the different R helix conformations, we wanted to study the nucleotide-bound state of the PDE within MorA.
Nucleotide bound state of MorA DGC-PDE
To obtain the c-di-GMP complex, we had to mix the tandem DGC-PDE 978-1409 wild type fragment with excess GTP immediately before crystallisation. Binding of c-di-GMP into the native PDE active site of MorA results in PDE dimerisation of the tandem fragment (Fig. 3A) . The orientation of PDE dimer is similar to the one observed within the isolated PDE 1145-1409 structure in the presence of 5'-pGpG ( Fig. 2) and (Table S2 ). The DGC domains in this dimer do not interaction with one another (Fig. 3B ).
In the nucleotide-bound form the R helix adopts the shorter conformation (L1319 to Q1324), compared to the wild type nucleotide free monomeric PDE (G1315 to Q1324) (Fig. 3C) . The shorter conformation of the R helix allows the extended loop conformation of the DDFGTG motif to contribute to active site formation, where residues D1310 and D1311 of the DDFGTG motif, along with residue E1189 of the EAL motif coordinate two Mg 2+ ions (Fig. 3C and SFig. 2). Interpretation of this c-di-GMP complex is that of a Michaelis complex that has yet to undergo activation (8) , as the tandem DGC-PDE is able to hydrolyse c-di-GMP to 5'pGpG (Fig. 1A) .
Comparison of the PDE domains presented here allows for an assignment of two distinct states ( Fig.   3C and Fig. 4) . The nucleotide-free structures show the repressed state with an incomplete active site, characterised by an extension of the R helix (PDE-α5), removes the DDFGTG motif from the active site and results in the loss of Mg 2+ binding. This state is different to the dimeric state of the PDE 1145-1409 and c-di-GMP bound DGC-PDE, where a shorter R helix is formed. Interactions at the dimeric interface stabilise the DDFGTGYSS motif into an extended loop conformation that allows the aspartates of the DDFGTG motif to bind Mg 2+ and contribute to active site formation. A further difference is observed with respect to the residue Tyr1389 that acts as a gate to the active site and is involved in base stacking of one of the c-di-GMP guanosine moieties ( Fig. 2A and Fig. 3C ).
When the nucleotide-free DGC-PDE mutant and the nucleotide-bound DGC-PDE structures are compared a slight rotation of twenty degrees is observed between the DGC and PDE domains (SFig.
4). The rotation suggests that a hinge, located on the H helix (hinge), links the DGC and PDE
domains. This hinge is located on the EAL domain side. Other orientations of the two domains might be possible.
Conclusion
The tandem DGC-PDE MorA structure represents the first structure determined for a dual active DGC and PDE enzyme. Monomer A and B ∆G of -4 kJ/mol with a surface area of 776.5 Å 2 .
Monomer A and B ∆G of -11.6 kJ/mol with a surface area of 1070.8 Å 2 .
